Clinical Trial Results:
A Two-part, Open-label, Multi-centre, Phase II Study in Patients with Advanced Solid Tumours, Consisting of a Randomised 2-period Crossover Protocol to Determine the Effect of Food upon the Pharmacokinetics of a Single Oral Dose of AZD2171 (Part A), Followed by a Randomised, Parallel-group Protocol to Assess the Safety, Tolerability and Efficacy of Multiple Doses of AZD2171 Administered as Either a Fixed Daily Dose of 45mg or an Individualised Dose Escalation Plan (Part B).
Summary
|
|
EudraCT number |
2005-003441-13 |
Trial protocol |
GB |
Global completion date |
01 Sep 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Oct 2016
|
First version publication date |
15 Oct 2016
|
Other versions |
|
Summary report(s) |
D8480C00021_CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.